AMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMN Healthcare Services Inc is not a strong buy for a beginner investor with a long-term strategy at this time. While there are some positive catalysts, the financial performance and technical indicators suggest caution. Holding off on investment until clearer growth trends emerge or technical signals improve would be prudent.
The stock's MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 35.355, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock closed below the pivot level (20.666), closer to the first support level (19.162), suggesting limited upward momentum in the short term.
Analysts have raised price targets recently, with some citing potential for industry stabilization and the company's ability to handle large-scale labor disruptions. Retention of the Kaiser contract adds a layer of stability.
The company's financial performance in Q4 2025 showed significant declines in net income (-95.90% YoY) and EPS (-95.92% YoY). Gross margin also dropped by 12%. Additionally, there is no recent news or significant insider/hedge fund activity to suggest a strong buy signal.
In Q4 2025, revenue increased by 1.84% YoY to $748.2M, but net income, EPS, and gross margin all dropped significantly, indicating poor profitability and operational efficiency.
Analysts have mixed views. Some have raised price targets (e.g., Citizens to $24, Baird to $23) and highlighted potential for growth in 2027. However, others maintain neutral ratings, reflecting near-term challenges and uneven conditions in the healthcare staffing sector.
